Clinical aspects of hypertension

Norman M Kaplan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A number of controversies concerning clinical aspects of hypertension are addressed. These include the need for out-of-the-office blood pressure readings in order not to incorrectly label the many people who have 'white-coat' elevations of pressure as being hypertensive. A second issue is determining the need for antihypertensive drug therapy after institution of an appropriate program of lifestyle modifications. Emphasis is placed upon the need to go beyond the level of blood pressure and to incorporate both the degree of target organ damage and the presence of concomitant cardiovascular risk factors in deciding upon the need for drug therapy, Once therapy is begun, the choice of initial therapy should be based upon certain demographic features and, mainly, the concomitant conditions that may be either adversely or positively influenced by the agent chosen. Since a J-curve of coronary disease likely exists, caution is advised not to lower the pressure below the lower limit of coronary perfusion. Lastly, the potential for prevention of hypertension is supported.

Original languageEnglish (US)
Pages (from-to)205-213
Number of pages9
JournalHypertension Research - Clinical and Experimental
Volume17
Issue number4
StatePublished - 1994

Fingerprint

Blood Pressure
Hypertension
Pressure
Drug Therapy
Antihypertensive Agents
Coronary Disease
Life Style
Reading
Perfusion
Demography
Therapeutics

Keywords

  • Clinical hypertension
  • Diagnosis of hypertension
  • Treatment of hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Clinical aspects of hypertension. / Kaplan, Norman M.

In: Hypertension Research - Clinical and Experimental, Vol. 17, No. 4, 1994, p. 205-213.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Clinical aspects of hypertension. In: Hypertension Research - Clinical and Experimental. 1994 ; Vol. 17, No. 4. pp. 205-213.
@article{41b45e5a14d34f678c33be5832ad4720,
title = "Clinical aspects of hypertension",
abstract = "A number of controversies concerning clinical aspects of hypertension are addressed. These include the need for out-of-the-office blood pressure readings in order not to incorrectly label the many people who have 'white-coat' elevations of pressure as being hypertensive. A second issue is determining the need for antihypertensive drug therapy after institution of an appropriate program of lifestyle modifications. Emphasis is placed upon the need to go beyond the level of blood pressure and to incorporate both the degree of target organ damage and the presence of concomitant cardiovascular risk factors in deciding upon the need for drug therapy, Once therapy is begun, the choice of initial therapy should be based upon certain demographic features and, mainly, the concomitant conditions that may be either adversely or positively influenced by the agent chosen. Since a J-curve of coronary disease likely exists, caution is advised not to lower the pressure below the lower limit of coronary perfusion. Lastly, the potential for prevention of hypertension is supported.",
keywords = "Clinical hypertension, Diagnosis of hypertension, Treatment of hypertension",
author = "Kaplan, {Norman M}",
year = "1994",
language = "English (US)",
volume = "17",
pages = "205--213",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Clinical aspects of hypertension

AU - Kaplan, Norman M

PY - 1994

Y1 - 1994

N2 - A number of controversies concerning clinical aspects of hypertension are addressed. These include the need for out-of-the-office blood pressure readings in order not to incorrectly label the many people who have 'white-coat' elevations of pressure as being hypertensive. A second issue is determining the need for antihypertensive drug therapy after institution of an appropriate program of lifestyle modifications. Emphasis is placed upon the need to go beyond the level of blood pressure and to incorporate both the degree of target organ damage and the presence of concomitant cardiovascular risk factors in deciding upon the need for drug therapy, Once therapy is begun, the choice of initial therapy should be based upon certain demographic features and, mainly, the concomitant conditions that may be either adversely or positively influenced by the agent chosen. Since a J-curve of coronary disease likely exists, caution is advised not to lower the pressure below the lower limit of coronary perfusion. Lastly, the potential for prevention of hypertension is supported.

AB - A number of controversies concerning clinical aspects of hypertension are addressed. These include the need for out-of-the-office blood pressure readings in order not to incorrectly label the many people who have 'white-coat' elevations of pressure as being hypertensive. A second issue is determining the need for antihypertensive drug therapy after institution of an appropriate program of lifestyle modifications. Emphasis is placed upon the need to go beyond the level of blood pressure and to incorporate both the degree of target organ damage and the presence of concomitant cardiovascular risk factors in deciding upon the need for drug therapy, Once therapy is begun, the choice of initial therapy should be based upon certain demographic features and, mainly, the concomitant conditions that may be either adversely or positively influenced by the agent chosen. Since a J-curve of coronary disease likely exists, caution is advised not to lower the pressure below the lower limit of coronary perfusion. Lastly, the potential for prevention of hypertension is supported.

KW - Clinical hypertension

KW - Diagnosis of hypertension

KW - Treatment of hypertension

UR - http://www.scopus.com/inward/record.url?scp=0028595748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028595748&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028595748

VL - 17

SP - 205

EP - 213

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 4

ER -